June 2026 – Participation in the first European Sports Concussion Conference (ESCC), held in Nice from 10 to 12 June 2026. This international event brought together researchers, clinicians, healthcare professionals and representatives from the world of sport to discuss the prevention, diagnosis and management of sports-related concussions.
During this event, REGEnLIFE presented an innovative, non-invasive medical device designed to target neuroinflammation, a key biological mechanism involved in sports-related concussions and recovery. It was an opportunity to exchange views and discuss with professionals committed to improving athletes’ brain health, the future of concussion care, and how mechanism-based therapeutic approaches can help improve athletes’ recovery outcomes. Our participation is part of our commitment to contributing to innovation and the development of science-based approaches in the field of head injuries.
Speakers: Guillaume Blivet, Jacques Touchon


